Low-Carb Diet & Liver Health | New Clinical Trial Findings

Comparing Dietary Approaches to Metabolic Health

Researchers at Washington University School of Medicine in St. Louis recently completed a five-month clinical trial assessing how different macronutrient ratios influence liver health and glucose regulation. The study monitored 55 adults diagnosed with metabolically unhealthy obesity, a condition defined by the presence of excess liver fat and prediabetes. Participants followed one of three specific dietary patterns: a high-fat ketogenic diet, a plant-forward high-carbohydrate diet, or a balanced Mediterranean diet. To ensure strict adherence, the research team provided every meal for all participants throughout the duration of the trial. Weekly check-ins with study dietitians provided additional oversight.

The findings, published August 27 in Cell Metabolism, indicate that weight loss remains the primary driver for improved insulin sensitivity in muscle tissue. Across all three groups, participants shed approximately 10% of their starting body weight. This uniform weight reduction corresponded to a 50% improvement in muscle insulin sensitivity, suggesting that the act of losing weight was more significant than the specific combination of proteins, fats, and carbohydrates consumed. That said, the metabolic outcomes diverged significantly when the researchers examined liver function and glycemic control.

Ketogenic Diet and Liver Function Outcomes

While weight loss alone helped all participants, the ketogenic diet produced superior results regarding internal organ health. Participants on the ketogenic plan experienced a 67% reduction in liver fat, compared to 45% for those on the other two dietary plans. Furthermore, the ketogenic diet improved insulin sensitivity in liver cells by a factor two to three times greater than the Mediterranean or high-carbohydrate options. This specific metabolic advantage is critical because fatty liver disease currently impacts 75% of adults living with obesity globally.

Blood sugar regulation also showed marked differences between the groups. Those following the ketogenic diet achieved a 20% drop in 24-hour blood glucose levels, whereas the other participants saw an 8% reduction. Insulin levels mirrored this trend, dropping 74% in the ketogenic group compared to lower rates in the other cohorts. The researchers noted that this decline in circulating insulin suggests the pancreas faces less strain when carbohydrate intake remains very low. Consequently, half of the individuals on the ketogenic diet fully reversed their prediabetes status, a notable contrast to the 29% and 7% rates seen in the Mediterranean and high-carbohydrate groups respectively.

Clinical Significance and Future Research Directions

These results clarify the relationship between weight loss and specific physiological improvements. Senior author Samuel Klein, the Danforth Professor of Medicine and Nutritional Science, noted that weight loss induced by a very low-carbohydrate diet provides therapeutic effects on glucose and lipid metabolism. These effects help prevent progression toward severe metabolic conditions that weight loss alone might not fully address. The study confirms that while standard weight reduction helps the body, the internal mechanisms of that change vary depending on what the person eats.

First author Max C. Petersen emphasized that diet choice retains clinical importance despite the rise of pharmaceutical interventions like GLP-1 medicines. While those drugs are effective for inducing weight loss, they do not replace the specific nutritional benefits found in this study. The team intends to investigate the exact mechanisms behind these metabolic changes in future trials, including how these dietary patterns interact with weight-loss medications. This research provides a roadmap for clinicians managing patients with prediabetes and fatty liver, moving the conversation beyond simple calorie counting to targeted nutritional strategies.